公开(公告)号：US06380369B1

公开(公告)日：2002-04-30

申请号：US08294312

申请日：1994-08-23

申请人： Mark D. Adams ,  Robert D. Fleischmann ,  Claire M. Fraser ,  Rebecca A. Fuldner ,  Ewen F. Kirkness ,  William A. Haseltine ,  Craig A. Rosen ,  Steve Ruben ,  Ying-Fei Wei

发明人： Mark D. Adams ,  Robert D. Fleischmann ,  Claire M. Fraser ,  Rebecca A. Fuldner ,  Ewen F. Kirkness ,  William A. Haseltine ,  Craig A. Rosen ,  Steve Ruben ,  Ying-Fei Wei

IPC分类号： C07H2102

CPC分类号： C07K14/47

摘要： The present invention discloses three human DNA repair proteins and DNA (RNA) encoding such proteins. The DNA repair proteins which may be produced by recombinant DNA techniques. One of the human DNA repair proteins, hMLH1, has been mapped to chromosome 3 while hMLH2 has been mapped to chromosome 2 and hMLH3 has been mapped to chromosome 7. The polynucleotide sequences of the DNA repair proteins may be used for diagnosis of a hereditary susceptibility to cancer.

摘要翻译： 本发明公开了三种人类DNA修复蛋白和编码这种蛋白质的DNA（RNA）。 可通过重组DNA技术产生的DNA修复蛋白。 人类DNA修复蛋白hMLH1已经被映射到染色体3，而hMLH2已被映射到染色体2，并且hMLH3已经被定位到染色体7上.DNA修复蛋白的多核苷酸序列可以用于诊断遗传易感性 到癌症。

公开(公告)号：US06482606B1

公开(公告)日：2002-11-19

申请号：US08187757

申请日：1994-01-27

申请人： Mark D. Adams ,  Robert D. Fleischmann ,  Claire M. Fraser ,  Rebecca A. Fuldner ,  Ewen F. Kirkness ,  William A. Haseltine ,  Craig A. Rosen ,  Steve Ruben ,  Ying-Fei Wei

发明人： Mark D. Adams ,  Robert D. Fleischmann ,  Claire M. Fraser ,  Rebecca A. Fuldner ,  Ewen F. Kirkness ,  William A. Haseltine ,  Craig A. Rosen ,  Steve Ruben ,  Ying-Fei Wei

IPC分类号： C12P2102

CPC分类号： C07K14/47

摘要： The present invention discloses three human DNA repair proteins and DNA (RNA) encoding such proteins. The DNA repair proteins may be produced by recombinant DNA techniques. One of the human DNA repair proteins, hmlh1, has been mapped on chromosome 3. The polynucleotide sequences of DNA repair proteins may be used for diagnosis of a hereditary susceptibility to cancer.

摘要翻译： 本发明公开了三种人类DNA修复蛋白和编码这种蛋白质的DNA（RNA）。 DNA修复蛋白可以通过重组DNA技术产生。 人类DNA修复蛋白之一hmlh1已被绘制在染色体3上.DNA修复蛋白的多核苷酸序列可用于诊断遗传性对癌症的易感性。

公开(公告)号：US07776555B1

公开(公告)日：2010-08-17

申请号：US11822094

申请日：2007-07-02

申请人： Bruno Domon ,  Steve Ruben ,  Charles E. Birse ,  Yeoun Jin Kim ,  Tao He ,  Ian McCaffery

发明人： Bruno Domon ,  Steve Ruben ,  Charles E. Birse ,  Yeoun Jin Kim ,  Tao He ,  Ian McCaffery

IPC分类号： G01N33/53

CPC分类号： G01N33/57419

摘要： The present invention provides a method for diagnosing and detecting diseases associated with colon. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in colon diseases (CCAT) and antibodies binds to CCAT. The present invention provides that CCAT is used as targets for screening agents that modulates the CCAT activities. Further the present invention provides methods for treating diseases associated with colon.

公开(公告)号：US07521195B1

公开(公告)日：2009-04-21

申请号：US11490329

申请日：2006-07-21

申请人： Elizabeth Joseloff ,  Aiqun Li ,  Tao He ,  Steve Ruben

发明人： Elizabeth Joseloff ,  Aiqun Li ,  Tao He ,  Steve Ruben

IPC分类号： G01N33/53

CPC分类号： G01N33/57423 ,  G01N2500/04 ,  Y10T436/143333

摘要： The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung diseases (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.

摘要翻译： 本发明提供了诊断和检测与肺相关疾病的方法。 本发明提供在肺部疾病（LCAT）中差异表达的一种或多种蛋白质或其片段，肽或核酸分子，并且抗体结合LCAT。 本发明提供LCAT作为调节LCAT活性的筛选剂的靶标。 此外，本发明提供了治疗与肺相关疾病的方法。

公开(公告)号：US07611703B1

公开(公告)日：2009-11-03

申请号：US11717149

申请日：2007-03-13

申请人： Elizabeth G. Joseloff ,  Yeoun Jin Kim ,  Tao He ,  Steve Ruben

发明人： Elizabeth G. Joseloff ,  Yeoun Jin Kim ,  Tao He ,  Steve Ruben

IPC分类号： A61K39/395

CPC分类号： C07K14/4748 ,  A61K2039/505 ,  C07K16/3038

摘要： The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.

摘要翻译： 本发明提供了诊断和检测与肾相关的疾病的方法。 本发明提供在肾脏疾病（KCAT）中差异表达的一种或多种蛋白质或其片段，肽或核酸分子，并且抗体结合KCAT。 本发明提供KCAT作为调节KCAT活性的筛选剂的靶标。 此外，本发明提供了治疗与肾相关的疾病的方法。

公开(公告)号：US20090123461A1

公开(公告)日：2009-05-14

申请号：US12255340

申请日：2008-10-21

申请人： William Fitzhugh ,  Steve Ruben ,  Vaibhav Narayan ,  Charles E. Birse

发明人： William Fitzhugh ,  Steve Ruben ,  Vaibhav Narayan ,  Charles E. Birse

IPC分类号： A61K39/395 ,  C07K14/00 ,  C07K16/00 ,  C07H21/00 ,  A01K67/027 ,  C12N15/63 ,  A61P35/00 ,  C12N5/10 ,  C12P21/00 ,  C12Q1/68 ,  G01N33/53

CPC分类号： C12Q1/6886 ,  A01K2217/05 ,  C07K14/705 ,  C12Q2600/136 ,  G01N2333/70596

摘要： The present invention provides a method for diagnosing and detecting cancer. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in cancer (podocalyxin) and antibodies that bind podocalyxins. The present invention provides that podocalyxins are used as targets for screening agents that modulate podocalyxin activities. Further the present invention provides methods for treating diseases associated with podocalyxin expression.

摘要翻译： 本发明提供一种诊断和检测癌症的方法。 本发明提供了一种或多种在癌症（podocalyxin）中差异表达的蛋白质或其片段，肽或核酸分子以及结合足芽荚膜球蛋白的抗体。 本发明提供了足孢菌素作为调节球蛋白活性的筛选剂的靶标。 此外，本发明提供了用于治疗与足荚体蛋白表达相关的疾病的方法。

公开(公告)号：US20070031419A1

公开(公告)日：2007-02-08

申请号：US11476141

申请日：2006-06-28

申请人： Bruno Domon ,  Charles Birse ,  Candy Lee ,  Steve Ruben

发明人： Bruno Domon ,  Charles Birse ,  Candy Lee ,  Steve Ruben

IPC分类号： A61K48/00 ,  C12Q1/68 ,  G01N33/53 ,  A61K39/395

CPC分类号： C07K16/28 ,  A61K2039/505 ,  C07K16/30 ,  C07K2317/73 ,  C12Q1/6886 ,  C12Q2600/136 ,  G01N33/574 ,  G01N33/57423 ,  G01N33/57438 ,  G01N2500/10 ,  G01N2800/52

摘要： Methods and compositions for detecting and treating a disease, particularly cancer, associated with differential expression of CDCP1 in disease cells compared to healthy cells. Also provided are antagonists or agonists of CDCP1, and methods for screening agents that modulate the CDCP1 level or activity in vivo or in vitro.

摘要翻译： 与健康细胞相比，用于检测和治疗与疾病细胞中CDCP1的差异表达相关的疾病，特别是癌症的方法和组合物。 还提供了CDCP1的拮抗剂或激动剂，以及筛选在体内或体外调节CDCP1水平或活性的药剂的方法。

公开(公告)号：US20050118679A1

公开(公告)日：2005-06-02

申请号：US10979092

申请日：2004-11-02

申请人： Jian Ni ,  Steve Ruben ,  Laurie Brewer ,  Reiner Gentz ,  Craig Rosen

发明人： Jian Ni ,  Steve Ruben ,  Laurie Brewer ,  Reiner Gentz ,  Craig Rosen

IPC分类号： A61K38/00 ,  C07K14/47 ,  C07K14/705 ,  C07K14/735 ,  C12N1/21 ,  C12N9/00 ,  C12N9/64 ,  C12N15/57 ,  C07H21/04 ,  A61K39/395 ,  C07K16/40

CPC分类号： C12N9/6489 ,  A61K38/00 ,  C07K14/47 ,  C07K14/705 ,  C07K14/70535 ,  C12N9/00 ,  C12N9/6475 ,  C12N9/6491 ,  C12N2799/026

摘要： The present invention relates to novel metalloproteinase-like proteins. In particular, isolated nucleic acid molecules are provided encoding the human TACE-like and matrilysin-like proteins. TACE-like and matrilysin-like polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TACE-like and matrilysin-like activity. Also provided are diagnostic methods for detecting cancer and therapeutic methods for cancer and other disorders characterized by an over or under production of these metalloproteinases.

摘要翻译： 本发明涉及新型金属蛋白酶样蛋白质。 特别地，提供了分离的核酸分子，其编码人类TACE样和基质溶素样蛋白。 TACE样和基质溶素样多肽也可以作为载体，宿主细胞和用于制备它们的重组方法提供。 本发明进一步涉及用于鉴定TACE样和基质溶素样活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测癌症的诊断方法和癌症的治疗方法以及特征在于这些金属蛋白酶过度或过量生产的其它病症。

公开(公告)号：US08486392B2

公开(公告)日：2013-07-16

申请号：US12901254

申请日：2010-10-08

申请人： Steve Ruben ,  Paul Moore ,  Tao He ,  Candy N. Lee ,  Karen Van Orden

发明人： Steve Ruben ,  Paul Moore ,  Tao He ,  Candy N. Lee ,  Karen Van Orden

IPC分类号： A61K39/395

CPC分类号： C07K16/3076 ,  A61K38/00 ,  A61K2039/505 ,  C07K14/4748 ,  C07K14/705 ,  C07K14/70546 ,  C07K14/70596 ,  C07K16/18 ,  C07K16/2839 ,  C07K16/2896 ,  C07K16/30 ,  C07K16/303 ,  C07K16/40 ,  C07K2317/54 ,  C07K2317/55 ,  C07K2317/56 ,  C07K2317/732 ,  C07K2317/734 ,  C12N9/18 ,  C12N9/6424 ,  C12N15/113 ,  C12N15/1137 ,  C12N15/1138 ,  C12N2310/14 ,  C12N2320/30 ,  C12Q1/6886 ,  C12Q2600/158 ,  C12Y301/01 ,  C12Y304/21 ,  C12Y304/21109 ,  G01N33/57488 ,  G01N33/57492

摘要： Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (CAT). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.

摘要翻译： 提供用于评估，治疗和预防使用癌症相关靶（CAT）的疾病，特别是癌症的方法和组合物。 还提供了用于确定或预测这些疾病的治疗或使用CAT选择治疗的有效性的方法和组合物。 还提供了使用CAT调节细胞功能的方法和组合物。 还提供了调节CAT（例如拮抗剂或激动剂）如抗体，蛋白质，小分子化合物和核酸试剂（例如RNAi和反义试剂）的组合物及其药物组合物。 进一步提供了筛选调节CAT的试剂的方法，以及通过这些筛选方法鉴定的试剂。

公开(公告)号：US08334106B2

公开(公告)日：2012-12-18

申请号：US13339833

申请日：2011-12-29

申请人： Steve Ruben ,  Candy N. Lee ,  Bruno Domon

发明人： Steve Ruben ,  Candy N. Lee ,  Bruno Domon

IPC分类号： G01N33/574

CPC分类号： G01N33/57484 ,  A61K38/00 ,  A61K47/6843 ,  A61K2039/505 ,  C07K14/47 ,  C07K16/18 ,  C07K2317/24 ,  C07K2317/54 ,  C07K2317/55 ,  C07K2317/56 ,  C07K2317/622 ,  C12N15/113 ,  C12N2310/14 ,  C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/118 ,  C12Q2600/136 ,  G01N33/574 ,  G01N33/57423 ,  G01N33/6893 ,  G01N2500/10 ,  Y10T436/143333

摘要： Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.